Attune Neurosciences
PrivateLast Round
Grant
Apr 10, 2026
Total Funding Raised
$4.72M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Attune Neurosciences is a medical device company that develops non-invasive neurostimulation products to treat central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Mental Health, Health IoT
Business Model
B2B
Customer Profile
Government Contracts, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attune Neurosciences Comparables
Compare Attune Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Highland Instruments | 83% | |
| Soterix Medical | 79% | |
| Neurosona | 78% | |
Attune Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 10, 2026 | ||||
| Accelerator | Feb 21, 2025 | ||||
| Grant | Sep 20, 2022 | ||||
| Seed | Oct 4, 2021 | ||||
| Grant | Sep 30, 2021 |
Key People
Founding team and executive leadership
Attune Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| One Mind | Accelerator |
| Genoa Ventures | Seed |
| ARPA-H | Grant |
| Prime Movers Lab | Seed |
| Satori Capital | Seed |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$4M raised from ARPA-H
- Jan 24, 2026
Monthly visitors grew 98% MoM, reaching 2.2K.
Attune Neurosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attune Neurosciences's valuation, stock price, and market status.